期刊文献+

缩硫脲类荧光探针分子的合成

Synthesis of the fluorescent probe molecule of thiosemicarbazones
原文传递
导出
摘要 目的合成带有Halo-tag专属性配基小分子的缩硫脲(缩氨基硫脲)化合物,作为研究抗肿瘤金属螯合剂作用机制的探针分子。方法以相应的酮为原料与肼基甲硫酸甲硫酯缩合,缩合物用2-(2-氨基乙氧基)乙醇取代其中甲硫基,得到重要中间体3酮缩4-[2-(2-羟基乙氧基)乙基]氨基硫脲,最后再与6-氯-1-溴己烷发生亲核取代反应生成目标化合物酮缩4-(2-[2-(6-氯己氧基)乙氧基]乙基)-3-氨基硫脲。目标化合物结构经1H-NMR、13C-NMR和LC-MS确认。结果与结论建立了抗肿瘤金属螯合剂与Halo-tag的专属性配基分子结合的制备路线,合成了3个连接Halo-tag专属性配基和高活性抗肿瘤金属螯合剂的探针分子,为研究该类抗肿瘤金属螯合剂的作用机制提供了工具分子。 Objective To synthesize the Halo-tag specific ligand of thiosemicarbazones that can be used as probe mole- cules to study the mechanism of action of anti-tumor metal chelators. Methods The target compounds, synthesized from ketone and methyl hydrazinecarbodithioate,reacted with 2-(2-aminoethoxy)ethanol to obtain intermediate 3 ketone- 4 [ 2 - (2 -hydroxyethoxy) ethyl ]-3- thiosemicarbazide before reacting with intermediate 3 and 1-bromo-6-chlorohexane via nucleo- philic substitution to obtain the target compounds ketone-4- (2 - (2 - (6- chlorohexyloxy)-ethoxy) ethyl)-3 thiosemicarbaz- ide. The structure of the compounds was confirmed by 1H-NMR, 13 C-NMR and LC-MS. Results and Conclusion A method of connecting Halo-tag specific ligand with anti-tumor metal chelators was established. Three fluorescent probe molecules of thiosemicarbazones were synthesized that can be used to study the mechanism of action of anti-tumor metal chelators.
出处 《军事医学》 CAS CSCD 北大核心 2013年第7期539-542,共4页 Military Medical Sciences
基金 国家科技支撑计划资助项目(2011BAI18B01)
关键词 HALOTAG 连接子 金属螯合剂 抗肿瘤 Halo-tag connexon metal-chelator antineoplastic
  • 相关文献

参考文献14

  • 1Samuni AM, Krishna MC, DeGraff W, et al. Mechanisms underlying the cytotoxic effects of tachpyr-a novel metal chelator [ J ]. Biochim Biophys Acta, 2002,1571 ( 3 ) :211 - 218.
  • 2Yu Y, Gutierrez E, Kovacevic Z, et al. Iron chelators for the treatment of cancer[J]. Curr Med Chem,2012,19(17) : 2689 -2702.
  • 3Yu Y, Kovacevic Z, Richardson DR. Tuning cell cycle regulation with an iron key[J]. Cell Cycle, 2007,6(16) : 1982 -1994.
  • 4Hancock CN, Stockwin LH, Han B, et al. A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo [ J ]. Free Radic Biol Med,2011,50( 1 ) : 110 - 121.
  • 5Kalinowski DS, Richardson DR. The evolution of iron chelators for treatment of iron overload disease and cancer[ J ] . Pharmacol Rev,2005,57 (4) :547 - 583.
  • 6Lovejoy DB, Sharp DM, Seebacher N, et al. Novel second- generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous adminis- tration in vivo[J]. J Med Chem, 2012, 55(16) : 7230 -7244.
  • 7Kalinowski DS, Yu Y, Sharpe PC, et al. Design, synthesis, and characterization of novel iron chelators: structure-activity relation- ships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoylanalogues as potent antitumor agents [ J ]. J Med Chem, 2007, 50(15) :3716 - 3729.
  • 8Merlot AM, Kalinowski DS, Richardson DR. Novel chelators for cancer treatment: where are we now[ J] ? Antioxid Redox Signal, 2013,18(8) :973 - 1006.
  • 9Yuan J, Lovejoy DB, Richardson DR. Novel di-2-pyridyl-derived iron chelators with marked and seleetive antitumor aetivity: in vitro and in vivo assessment [ J ]. Blood, 2004,104 ( 5 ) : 1450 - 1458.
  • 10Los GV, Encell LP, McDougall MG, et al. Halo-tag: a novel protein labeling technology for cell imaging and protein analysis [J]. ACS Chem Biol, 2008,3(6) :373 -382.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部